| Literature DB >> 33186557 |
Xiao Wang1, Huimin Wang2, Bolin Xu3, Dong Huang3, Chao Nie3, Longjun Pu2, Gregory J M Zajac4, Han Yan3, Jingru Zhao2, Fangyuan Shi5, Brian T Emmer6, Jia Lu3, Rui Wang2, Xiaohui Dong3, Jianye Dai7, Wenjing Zhou3, Chu Wang8, Ge Gao5, Yan Wang9, Cristen Willer4, Xiangfeng Lu10, Yuangang Zhu1, Xiao-Wei Chen11.
Abstract
Efficient delivery of specific cargos in vivo poses a major challenge to the secretory pathway, which shuttles products encoded by ∼30% of the genome. Newly synthesized protein and lipid cargos embark on the secretory pathway via COPII-coated vesicles, assembled by the GTPase SAR1 on the endoplasmic reticulum (ER), but how lipid-carrying lipoproteins are distinguished from the general protein cargos in the ER and selectively secreted has not been clear. Here, we show that this process is quantitatively governed by the GTPase SAR1B and SURF4, a high-efficiency cargo receptor. While both genes are implicated in lipid regulation in humans, hepatic inactivation of either mouse Sar1b or Surf4 selectively depletes plasma lipids to near-zero and protects the mice from atherosclerosis. These findings show that the pairing between SURF4 and SAR1B synergistically operates a specialized, dosage-sensitive transport program for circulating lipids, while further suggesting a potential translation to treat atherosclerosis and related cardio-metabolic diseases.Entities:
Keywords: COPII; cardio-metabolic disease; human genetics; lipid homeostasis; lipoprotein receptor; secretion
Year: 2020 PMID: 33186557 DOI: 10.1016/j.cmet.2020.10.020
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287